Norethindrone Tablet
Product Images NDC 0378-7292

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Norethindrone (NDC 0378-7292). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

D995e0c0 9fa7 440f 8646 C54c3967fc7c 01

Chemical structure of norethindrone, the active ingredient in NORETHINDRONE tablets. The diagram shows the molecular framework including rings and functional groups characteristic of the steroidal compound.*

FDA Label Image

D995e0c0 9fa7 440f 8646 C54c3967fc7c 02

A pharmacokinetic plasma concentration-time curve for norethindrone 0.35 mg oral tablet. The X-axis shows time in hours up to 48 hours, and the Y-axis shows concentration in pg/mL. The curve depicts peak concentration early after dosing, followed by a rapid decline to near baseline by 48 hours.*

FDA Label Image

Image 01

Norethindrone Tablets, USP 0.35 mg oral tablets packaging label from Mylan Pharmaceuticals Inc. The carton indicates that 3 pouches are included, each containing a blister pack of 28 tablets. The label features dosage strength prominently and includes storage instructions and a warning about the product's contraceptive use.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.